A disintegrin and metalloprotease with thrombospondin motif 2 may contribute to cirrhosis in humans through the transforming growth factor-β/SMAD pathway

Gut and Liver

Volumn 7, Issue 2, 2013, Pages 213-220

  Dong, Chao ^a   Li, Han Jun ^a,b   Chang, Shi ^a   Liao, Hui Jun ^a   Zhang, Zhi Peng ^a   Huang, Peng ^a   Tang, Hui Huan ^a  

^a Central South University   (China)

^b WUHAN GENERAL HOSPITAL OF GUANGZHOU COMMAND   (China)

Author keywords

A disintegrin and metalloprotease with thrombospondin motif 2; Cirrhosis; Humans; Transforming growth factor beta 1

Indexed keywords

COLLAGEN; DISINTEGRIN; GELATINASE A; SMAD2 PROTEIN; SMAD3 PROTEIN; THROMBOSPONDIN 2; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; ARTICLE; CLINICAL ARTICLE; CORRELATION ANALYSIS; DISEASE COURSE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER; LIVER CIRRHOSIS; MALE; PORTAL HYPERTENSION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING;

EID: 84875098240     PISSN: 19762283     EISSN: None     Source Type: Journal    
DOI: 10.5009/gnl.2013.7.2.213     Document Type: Article

References (16)

1. Kirmaz C, Terzioglu E, Topalak O, et al. Serum transforming growth factor-beta1 (TGF-beta1) in patients with cirrhosis, chronic hepatitis B and chronic hepatitis C [corrected]. Eur Cytokine Netw 2004;15:112-116.
2. Li HJ, Dong C, Chang S. Effect of transforming growth factor-?1 on thrombospondin-1 in hepatic fibrosis. Chin J Exp Surg 2010;27:1674-1676.
3. Inagaki Y, Okazaki I. Emerging insights into transforming growth factor beta Smad signal in hepatic fibrogenesis. Gut 2007;56:284-292.
4. Iredale JP. Hepatic stellate cell behavior during resolution of liver injury. Semin Liver Dis 2001;21:427-436.
5. Colige A, Ruggiero F, Vandenberghe I, et al. Domains and maturation processes that regulate the activity of ADAMTS-2, a metalloproteinase cleaving the aminopropeptide of fibrillar procollagens types I-III and V. J Biol Chem 2005;280:34397-34408.
6. Yung S, Lee CY, Zhang Q, Lau SK, Tsang RC, Chan TM. Elevated glucose induction of thrombospondin-1 up-regulates fibronectin synthesis in proximal renal tubular epithelial cells through TGF-beta1 dependent and TGF-beta1 independent pathways. Nephrol Dial Transplant 2006;21:1504-1513.
7. Brenner DA, Westwick J, Breindl M. Type I collagen gene regulation and the molecular pathogenesis of cirrhosis. Am J Physiol 1993;264(4 Pt 1):G589-G595.
8. Kesteloot F, Desmouliere A, Leclercq I, et al. ADAM metallopeptidase with thrombospondin type 1 motif 2 inactivation reduces the extent and stability of carbon tetrachloride-induced hepatic fibrosis in mice. Hepatology 2007;46:1620-1631.
9. Nicholson AC, Malik SB, Logsdon JM Jr, Van Meir EG. Functional evolution of ADAMTS genes: evidence from analyses of phylogeny and gene organization. BMC Evol Biol 2005;5:11.
10. Wang WM, Lee S, Steiglitz BM, et al. Transforming growth factor-beta induces secretion of activated ADAMTS-2. A procollagen III N-proteinase. J Biol Chem 2003;278:19549-19557.
11. Schwettmann L, Wehmeier M, Jokovic D, et al. Hepatic expression of A disintegrin and metalloproteinase (ADAM) and ADAMs with thrombospondin motives (ADAM-TS) enzymes in patients with chronic liver diseases. J Hepatol 2008;49:243-250.
12. Moss ML, Bartsch JW. Therapeutic benefits from targeting of ADAM family members. Biochemistry 2004;43:7227-7235.
13. Le Goff C, Cormier-Daire V. The ADAMTS(L) family and human genetic disorders. Hum Mol Genet 2011;20(R2):R163-R167.
14. Kato J, Ido A, Hasuike S, et al. Transforming growth factor-beta-induced stimulation of formation of collagen fiber network and anti-fibrotic effect of taurine in an in vitro model of hepatic fibrosis. Hepatol Res 2004;30:34-41.
15. Nakano S, Nagasawa T, Ijiro T, et al. Bezafibrate prevents hepatic stellate cell activation and fibrogenesis in a murine steatohepatitis model, and suppresses fibrogenic response induced by transforming growth factor-beta1 in a cultured stellate cell line. Hepatol Res 2008;38:1026-1039.
16. Kondou H, Mushiake S, Etani Y, Miyoshi Y, Michigami T, Ozono K. A blocking peptide for transforming growth factor-beta1 activation prevents hepatic fibrosis in vivo. J Hepatol 2003;39:742-748.